Diegem, 18 december 2019 – De week voor Kerstmis is traditioneel de warmste, ook bij Bayer. Net zoals vorig jaar hebben de verschillende teams van de Belgische Bayer-vestigingen acties georganiseerd voor De Warmste Week. De medewerkers hebben in totaal 19.000 euro opgehaald ten voordele van de Belgische Cardiologische Liga. Het Clinical Operations team heeft de meest succesvolle actie opgezet en zal de cheque overhandigen in Kortrijk.

• Eigen activiteiten moeten koolstofneutraal zijn tegen 2030
• Ambitieuze doelstellingen tegen 2030 voor toegang tot gezondheid en voeding in landen met lage en gemiddelde inkomsten en onderbediende gemeenschappen
• Meetbare duurzaamheidsdoelstellingen op te nemen in managementvergoedingen

• Group sales increase by 5.4 percent (Fx & portfolio adj.) to 9.830 billion euros
• EBITDA before special items advances by 7.5 percent to 2.291 billion euros
• Crop Science reports higher sales and substantial earnings growth
• Pharmaceuticals increases sales – earnings decline due to one-time income in prior year
• Consumer Health posts growth in sales (Fx & portfolio adj.) and earnings
• Net income declines by 63.9 percent to 1.036 billion euros – substantial divestment gain included in prior year
• Core earnings per share up by 6.4 percent to 1.16 euros
• Group outlook confirmed and aligned to continuing operations

• Agriculture is part of the solution for climate change
• Investing more than 25 billion euros in Crop Science R&D over the next 10 years
• Leading Digital Farming platform FieldView on 90 million paid acres this year

• Implied total company value of up to USD 1 billion, inclusive of 40.8 percent stake currently held by Bayer
• Initial focus in neurology, cardiology, and immunology with start of first clinical program in Parkinson’s disease expected later this year
• BlueRock Therapeutics to continue to operate as an independent company